Library

Agency issuances

16,884 issuances · 1941–2026

2014 FDA Circular

19 issuances in 2014

Newest first
  1. Nov 21, 2014 FDA Circular No. 2014-028 GUIDELINES ON THE IMPLEMENTATION OF NEW RULES AND REGULATIONS ON THE LICENSING OF RETAIL OUTLET FOR NON- PRESCRIPTION DRUGS (RONPDS) FOLLOWING ADMINISTRATIVE ORDER NO. 2014-0034, DATED 13 OCTOBER 2014
  2. Nov 21, 2014 FDA Circular No. 2014-027 GUIDELINES ON THE IMPLEMENTATION OF NEW RULES AND REGULATIONS ON THE LICENSING OF DRUG MANUFACTURER FOLLOWING ADMINISTRATIVE ORDER NO. 2014-0034, DATED 13 OCTOBER 2014
  3. Nov 21, 2014 FDA Circular No. 2014-026 GUIDELINES ON THE IMPLEMENTATION OF NEW RULES AND REGULATIONS ON THE LICENSING OF DRUG DISTRIBUTORS FOLLOWING ADMINISTRATIVE ORDER NO. 2014-0034, DATED 13 OCTOBER 2014
  4. Nov 21, 2014 FDA Circular No. 2014-025 GUIDELINES ON THE IMPLEMENTATION OF NEW RULES AND REGULATIONS ON THE LICENSING OF DRUGSTORE/PHARMACY/BOTICA AND SIMILAR OUTLETS FOLLOWING ADMINISTRATIVE ORDER NO. 2014-0034, DATED 13 OCTOBER 2014
  5. Jul 1, 2014 FDA Circular No. 2014-014 MINIMUM NUMBER OF SAMPLE UNITS REQUIRED FOR EACH TEST ANALYSIS
  6. May 30, 2014 FDA Circular No. 2014-016 IMPLEMENTING GUIDELINES FOR ADMINISTRATIVE ORDER NO. 2013-0022 DATED 13 AUGUST 2013, SUBJECT: GUIDELINES FOR CURRENT GOOD MANUFACTURING PRACTICE (CGMP) CLEARANCE AND INSPECTION OF FOREIGN DRUG MANUFACTURERS
  1. May 21, 2014 FDA Circular No. 2014-013 RE-ASSESSMENT OF THE APPLICATION OF STEM CELL THERAPY FOR CORNEAL RESURFACING WITH LIMBAL STEM CELLS
  2. Apr 29, 2014 FDA Circular No. 2014-011 ADOPTION OF UNIQUE GLOBAL PRODUCT IDENTIFICATION NUMBER
  3. Apr 24, 2014 FDA Circular No. 2014-010 SALE AND DISTRIBUTION OF EMPTY GELATIN CAPSULES
  4. Apr 14, 2014 FDA Circular No. 2014-012 REQUIRING PROOF OF COURIER SERVICE PAYMENT FOR PROMOTION AND ADVERTISEMENT PERMITS
  5. Apr 7, 2014 FDA Circular No. 2014-009 FILING AND SUBMISSION OF APPLICATIONS FOR THE APPROVAL OF CLINICAL TRIAL PROTOCOL, COMPASSIONATE SPECIAL PERMIT (CSP), IMPORT PERMIT FOR INVESTIGATIONAL DRUG PRODUCTS, PHARMACOVIGILANCE, ADVERSE EVENTS/ADVERSE REACTION REPORTS, AND OTHER RELATED DOCUMENTS
  6. Apr 1, 2014 FDA Circular No. 2014-008
  7. Feb 25, 2014 FDA Circular No. 2014-007 ADOPTION OF THE KUALA LUMPUR PRINCIPLES DEVICE SECTOR CODE OF ETHICS
  8. Feb 24, 2014 FDA Circular No. 2014-006 APPLICATION FOR LTO VARIATION
  9. Feb 20, 2014 FDA Circular No. 2014-005 PROHIBITION OF THE OPERATION OF RADIOGRAPHIC X- RAY MACHINES WITH TUBE CURRENTS BELOW 100 mA IN DIAGNOSTIC RADIOLOGY
  10. Feb 19, 2014 FDA Circular No. 2014-004 EXTENSION OF SIX-MONTH MORATORIUM ON THE REQUIREMENT OF CERTIFICATE OF PRODUCT REGISTRATION FOR RAW MATERIALS TO BE PRESENTED TO THE BUREAU OF CUSTOMS (BOC) PRIOR TO RELEASE PER FDA MEMORANDUM CIRCULAR (FMC) NO. 2013-032 AND FMC NO. 2013-035 UNTIL 31 AUGUST 2014
  11. Feb 17, 2014 FDA Circular No. 2014-003 FILING AND RECEIVING OF REGISTRATION, LICENSING AND OTHER APPLICATIONS USING THE INTEGRATED APPLICATION FORM
  12. Feb 7, 2014 FDA Circular No. 2014-002 FILING OF APPLICATIONS FOR AUTHORIZATIONS BY REGION IV-A (CALABARZON) ESTABLISHMENTS IN FDA CENTRAL OFFICE
  13. Jan 9, 2014 FDA Circular No. 2014-001 TRAINING COURSES AND SCHEDULE OF FEES FOR THE TRAININGS OFFERED BY THE FDA ACADEMY – POLICY PLANNING OFFICE FOR CALENDAR YEAR 2014